Their lead program, AEB1102, aims to lower elevated arginine within the blood as enzyme replacement therapy for Arginase 1 deficiency and remedy of arginine-dependent tumors. With an amino acids supplier for nutraceuticals acid volume share of 56.8% within the food and dietary supplements application in 2022, it is anticipated to continue to steer the market...